Immune cell infiltration in malignant middle cerebral artery infarction: Comparison with transient cerebral ischemia

Journal of Cerebral Blood Flow and Metabolism

Volumn 34, Issue 3, 2014, Pages 450-459

  Chu, Hannah X ^a   Kim, Hyun Ah ^a   Lee, Seyoung ^a   Moore, Jeffrey P ^a   Chan, Christopher T ^a   Vinh, Antony ^a   Gelderblom, Mathias ^b   Arumugam, Thiruma V ^c   Broughton, Brad Rs ^a   Drummond, Grant R ^a   Sobey, Christopher G ^a  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

immune cell infiltration; inflammation; leukocytes; malignant middle cerebral artery infarction; middle cerebral artery occlusion; stroke

Indexed keywords

CD11B ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; BRAIN ISCHEMIA; CD4+ T LYMPHOCYTE; CELL INFILTRATION; CELL TYPE; CEREBRAL ARTERY DISEASE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY REPERFUSION; DENDRITIC CELL; FLOW CYTOMETRY; HEMISPHERE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; INFLAMMATORY CELL; LEUKOCYTE; LYMPHOID CELL; MACROPHAGE; MALE; MICROGLIA; MIDDLE CEREBRAL ARTERY OCCLUSION; MOUSE; NATURAL KILLER T CELL; NEUTROPHIL; NONHUMAN; PARENCHYMA; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; CHEMOTAXIS, LEUKOCYTE; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; IMMUNOHISTOCHEMISTRY; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; LYMPHOCYTES; MALE; MICE; MICE, INBRED C57BL; NEUTROPHIL INFILTRATION; TIME FACTORS;

EID: 84896738742     PISSN: 0271678X     EISSN: 15597016     Source Type: Journal    
DOI: 10.1038/jcbfm.2013.217     Document Type: Article

References (40)

1. Roger VL, Go AS, Lloyd-Jones DM, Benjamin EJ, Berry JD, Borden WB et al. Heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation 2012; 125: e2-e220.
2. Del Zoppo GJ, Saver JL, Jauch EC, Adams Jr. HP. Expansion of the time window for treatment of acute ischemic stroke with intravenous tissue plasminogen activator: a science advisory from the American Heart Association/American Stroke Association. Stroke 2009; 40: 2945-2948.
3. Frank JI. Large hemispheric infarction, deterioration, and intracranial pressure. Neurology 1995; 45: 1286-1290.
4. Berrouschot J, Sterker M, Bettin S, Koster J, Schneider D. Mortality of spaceoccupying (?malignant?) middle cerebral artery infarction under conservative intensive care. Intensive Care Med 1998; 24: 620-623.
5. Hacke W, Schwab S, Horn M, Spranger M, De Georgia M, von Kummer R. ?Malignant? middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 1996; 53: 309-315.
6. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology 1995; 45: S10-S14.
7. McKenna A, Wilson CF, Caldwell SB, Curran D. Functional outcomes of decompressive hemicraniectomy following malignant middle cerebral artery infarctions: a systematic review. Br J Neurosurg 2012; 26: 310-315.
8. Gelderblom M, Leypoldt F, Steinbach K, Behrens D, Choe CU, Siler DA et al. Temporal and spatial dynamics of cerebral immune cell accumulation in stroke. Stroke 2009; 40: 1849-1857.
9. Akopov SE, Simonian NA, Grigorian GS. Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage. Stroke 1996; 27: 1739-1743.
10. Weston RM, Jones NM, Jarrott B, Callaway JK. Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury. J Cereb Blood Flow Metab 2007; 27: 100-114.
11. Brait VH, Rivera J, Broughton BR, Lee S, Drummond GR, Sobey CG. Chemokinerelated gene expression in the brain following ischemic stroke: no role for CXCR2 in outcome. Brain Res 2011; 1372: 169-179.
12. Emerich DF, Dean 3rd RL, Bartus RT. The role of leukocytes following cerebral ischemia: pathogenic variable or bystander reaction to emerging infarct? Exp Neurol 2002; 173: 168-181.
13. Brait VH, Arumugam TV, Drummond GR, Sobey CG. Importance of T lymphocytes in brain injury, immunodeficiency, and recovery after cerebral ischemia. J Cereb Blood Flow Metab 2012; 32: 598-611.
14. Brait VH, Jackman KA, Walduck AK, Selemidis S, Diep H, Mast AE et al. Mechanisms contributing to cerebral infarct size after stroke: gender, reperfusion, T lymphocytes, and Nox2-derived superoxide. J Cereb Blood Flow Metab 2010; 30: 1306-1317.
15. Yilmaz G, Arumugam TV, Stokes KY, Granger DN. Role of T lymphocytes and interferon-gamma in ischemic stroke. Circulation 2006; 113: 2105-2112.
16. Ren X, Akiyoshi K, Dziennis S, Vandenbark AA, Herson PS, Hurn PD et al. Regulatory B cells limit CNS inflammation and neurologic deficits in murine experimental stroke. J Neurosci 2011; 31: 8556-8563.
17. Kilkenny C, Browne WJ, Cuthill IC, Emerson M, Altman DG. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol 2010; 8: e1000412.
18. Chamorro A, Meisel A, Planas AM, Urra X, van de Beek D, Veltkamp R. The immunology of acute stroke. Nat Rev Neurol 2012; 8: 401-410.
19. Barone FC, Hillegass LM, Tzimas MN, Schmidt DB, Foley JJ, White RF et al. Timerelated changes in myeloperoxidase activity and leukotriene B4 receptor binding reflect leukocyte influx in cerebral focal stroke. Mol Chem Neuropathol 1995; 24: 13-30.
20. Stowe AM, Adair-Kirk TL, Gonzales ER, Perez RS, Shah AR, Park TS et al. Neutrophil elastase and neurovascular injury following focal stroke and reperfusion. Neurobiol Dis 2009; 35: 82-90.
21. Price CJ, Menon DK, Peters AM, Ballinger JR, Barber RW, Balan KK et al. Cerebral neutrophil recruitment, histology, and outcome in acute ischemic stroke: an imaging-based study. Stroke 2004; 35: 1659-1664.
22. Jiang N, Chopp M, Chahwala S. Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Res 1998; 788: 25-34.
23. Zhang L, Zhang ZG, Zhang RL, Lu M, Krams M, Chopp M. Effects of a selective CD11b/CD18 antagonist and recombinant human tissue plasminogen activator treatment alone and in combination in a rat embolic model of stroke. Stroke 2003; 34: 1790-1795.
24. Krams M, Lees KR, Hacke W, Grieve AP, Orgogozo JM, Ford GA. Acute Stroke Therapy by Inhibition of Neutrophils (ASTIN): an adaptive dose-response study of UK-279,276 in acute ischemic stroke. Stroke 2003; 34: 2543-2548.
25. Denes A, Vidyasagar R, Feng J, Narvainen J, McColl BW, Kauppinen RA et al. Proliferating resident microglia after focal cerebral ischaemia in mice. J Cereb Blood Flow Metab 2007; 27: 1941-1953.
26. McIver Z, Serio B, Dunbar A, O?Keefe CL, Powers J, Wlodarski M et al. Doublenegative regulatory T cells induce allotolerance when expanded after allogeneic haematopoietic stem cell transplantation. Br J Haematol 2008; 141: 170-178.
27. Wong CH, Jenne CN, Lee WY, Leger C, Kubes P. Functional innervation of hepatic iNKT cells is immunosuppressive following stroke. Science 2011; 334: 101-105.
28. Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol 2013; 13: 101-117.
29. Liesz A, Zhou W, Mracsko E, Karcher S, Bauer H, Schwarting S et al. Inhibition of lymphocyte trafficking shields the brain against deleterious neuroinflammation after stroke. Brain 2011; 134: 704-720.
30. Gobel K, Bittner S, Melzer N, Pankratz S, Dreykluft A, Schuhmann MK et al. CD4(?) CD25(?) FoxP3(?) regulatory T cells suppress cytotoxicity of CD8(?) effector T cells: implications for their capacity to limit inflammatory central nervous system damage at the parenchymal level. J Neuroinflammation 2012; 9: 41.
31. Liesz A, Suri-Payer E, Veltkamp C, Doerr H, Sommer C, Rivest S et al. Regulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke. Nat Med 2009; 15: 192-199.
32. Kleinschnitz C, Kraft P, Dreykluft A, Hagedorn I, Gobel K, Schuhmann MK et al. Regulatory T cells are strong promoters of acute ischemic stroke in mice by inducing dysfunction of the cerebral microvasculature. Blood 2013; 121: 679-691.
33. Stubbe T, Ebner F, Richter D, Engel O, Klehmet J, Royl G et al. Regulatory T cells accumulate and proliferate in the ischemic hemisphere for up to 30 days after MCAO. J Cereb Blood Flow Metab 2012; 33: 37-47.
34. Offner H, Hurn PD. A Novel Hypothesis: Regulatory B Lymphocytes Shape Outcome from Experimental Stroke. Transl Stroke Res 2012; 3: 324-330.
35. Zhou W, Liesz A, Bauer H, Sommer C, Lahrmann B, Valous N et al. Postischemic brain infiltration of leukocyte subpopulations differs among murine permanent and transient focal cerebral ischemia models. Brain Pathol 2013; 23: 34-44.
36. Kostulas N, Li HL, Xiao BG, Huang YM, Kostulas V, Link H. Dendritic cells are present in ischemic brain after permanent middle cerebral artery occlusion in the rat. Stroke 2002; 33: 1129-1134.
37. Reichmann G, Schroeter M, Jander S, Fischer HG. Dendritic cells and dendritic-like microglia in focal cortical ischemia of the mouse brain. J Neuroimmunol 2002; 129: 125-132.
38. Steptoe RJ, Thomson AW. Dendritic cells and tolerance induction. Clin Exp Immunol 1996; 105: 397-402.
39. Juttler E, Schwab S, Schmiedek P, Unterberg A, Hennerici M, Woitzik J et al. Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): a randomized, controlled trial. Stroke 2007; 38: 2518-2525.
40. Sandoval KE, Witt KA. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol Dis 2008; 32: 200-219.